Share: Facebook Twitter GooglePLus LinkedIn
Activity Provided By:

University of Connecticut School of Pharmacy

New Oral Anticoagulants: Factor IIa and Xa Inhibitors

Access Activity

Overview / Abstract:

In this knowledge-based continuing pharmacy education activity Dr Michael Smith, RPh, PharmD, CACP discusses the new oral anticoagulation agents.

Target Audience:
Pharmacists who are interested in the management of patients on anticoagulation therapy and/or who are interested in starting pharmacy services for patients on anticoagulation therapy

This activity is not accredited for technicians

Learning objectives:
At the conclusion of the activity, pharmacists will be able to:

1. Discuss the mechanism of action, indications, contraindication and adverse effects
2. Discuss the available monitoring and reversibility of these agents
3. Identify patients that may benefit from the new agents and those that may not


May 15, 2019


Pharmacy CPE


Online, Seminar



Credits / Hours




Presenters / Authors / Faculty

Michael Smith, RPh, PharmD, BCPS, CACP
East Region Clinical Manager, Pharmacy
Hartford Healthcare
William W Backus Hospital
Norwich, CT

Activity Specialities / Related Topics

Anticoagulation / Thrombosis, Pharmacology

Sponsors / Supporters / Grant Providers

This activity has been supported by an educational grant from CSL Behring

Keywords / Search Terms

University of Connecticut School of Pharmacy University of Connecticut Anticoagulation, Oral Anticoagulants

Access Activity

RXinsider,, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the website or within our mobile apps. RXinsider,, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or or within our mobile apps. For complete details, please read the Terms of Service. Site Map.